# TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study

> **NCT02752932** · NA · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 41 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **OTHER:** Drug testing on PDX per Investigator's choice (upto 4)

## Key facts

- **NCT ID:** NCT02752932
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2017-10-12
- **Final completion:** 2017-10-12
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2017-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02752932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02752932, "TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT02752932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*